Learning objectives
After watching this webinar, participants will understand:
Needs assessment and expected educational outcome
To present current evidence and to anticipate future trends concerning the role of biomarkers in the cardiovascular risk assessment of T2DM patients. To present optimal cardioprotective treatment for such patients.
This programme is supported by Roche Diagnostics International Ltd. in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.
Main Topic
Related Topic
Session information
This webinar is designed for all healthcare professionals having an interest in Heart Failure.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).